Component

L-Glutamyl-L-glutamate / Glu-Glu

Alpha-linked glutamyl dipeptide tested in the human sweet-receptor expression assay; not gamma-glutamylcysteine.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Coapplied Glu-Glu attenuated the sucrose-evoked calcium response in cells expressing human TAS1R2/TAS1R3.

    Experimental context and source evidence
    dose
    Sucrose concentration series up to 150 mM; MSG or Glu-Glu/Glu-Asp concentration series; mutant imaging used 100 mM sucrose with 1 mM Glu-Glu or 50 mM MSG
    duration
    120-second fluorescence acquisition; imaging at 30 seconds
    evidence_access
    Primary full-text methods/results and metadata inspected.
    evidence_scope
    literature_reviewed; source-specific curation
    experimental_model
    Human TAS1R2/TAS1R3 in Flp-In 293 cells
    exposure_scope
    Nutrient and peptide modulation of human sweet receptor
    limitations
    Cellular response, not a direct binding assay or a demonstration that every food tastes less sweet. pH/osmolarity controls and agonist-specific responses limit interpretation. Doses differ among panels.
    nutrient_topic
    Sucrose chapter; direct sucrose observations are distinguished from shared component metabolism. · Sucrose
    organism
    Human TAS1R2/TAS1R3 in Flp-In 293 cells
    plain_language
    Coapplied Glu-Glu attenuated the sucrose-evoked calcium response in cells expressing human TAS1R2/TAS1R3.
    primary_references
    Modulation of sweet taste by umami compounds via sweet taste receptor subunit hT1R2. (2015). https://pubmed.ncbi.nlm.nih.gov/25853419/ DOI: 10.1371/journal.pone.0124030
    route
    In vitro coapplication
    tissue
    Sweet-receptor calcium signaling

    Sucrose: mechanism of action and metabolic impact (2026-09-20) · lines 91–101

    Original AI-assisted source-specific sucrose curation with shared canonical claims retained by identity. Primary-study citations, negative findings, exposure details and limitations preserved. Not publisher full text. · supports · Human TAS1R2/TAS1R3 in Flp-In 293 cells · source_derived_draft · unverified_draft

    ## sucrose-gluglu-receptor Coapplied Glu-Glu attenuated the sucrose-evoked calcium response in cells expressing human TAS1R2/TAS1R3. Model/species: Human TAS1R2/TAS1R3 in Flp-In 293 cells Tissue: Sweet-receptor calcium signaling Exposure: Sucrose concentration series up to 150 mM; MSG or Glu-Glu/Glu-Asp concentration series; mutant imaging used 100 mM sucrose with 1 mM Glu-Glu or 50 mM MSG Route: In vitro coapplication Duration: 120-second fluorescence acquisition; imaging at 30 seconds Exposure scope: Nutrient and peptide modulation of human sweet receptor Limits: Cellular response, not a direct binding assay or a demonstration that every food tastes less sweet. pH/osmolarity controls and agonist-specific responses limit interpretation. Doses differ among panels. Reference: Modulation of sweet taste by umami compounds via sweet taste receptor subunit hT1R2. (2015). https://pubmed.ncbi.nlm.nih.gov/25853419/ DOI: 10.1371/journal.pone.0124030 Access: Primary full-text methods/results and metadata inspected.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards